Baxter 20 mmol Potassium Chloride, 5% Glucose and 0.45% Sodium Chloride injection for intravenous infusion 1000 mL bag (AHB6024) 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

baxter 20 mmol potassium chloride, 5% glucose and 0.45% sodium chloride injection for intravenous infusion 1000 ml bag (ahb6024)

baxter healthcare pty ltd - potassium chloride, quantity: 1.49 g/l; glucose, quantity: 50 g/l; sodium chloride, quantity: 4.5 g/l - injection - excipient ingredients: water for injections - the potassium chloride, sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Baxter 20 mmol Potassium Chloride, 5% Glucose and 0.9% Sodium Chloride injection for intravenous infusion 1000 mL bag (AHB6066) 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

baxter 20 mmol potassium chloride, 5% glucose and 0.9% sodium chloride injection for intravenous infusion 1000 ml bag (ahb6066)

baxter healthcare pty ltd - potassium chloride, quantity: 1.49 g/l; glucose, quantity: 50 g/l; sodium chloride, quantity: 9 g/l - injection - excipient ingredients: water for injections - the potassium chloride, sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 5% GLUCOSE INTRAVENOUS INFUSION glucose 1000mL bag 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

baxter 5% glucose intravenous infusion glucose 1000ml bag

baxter healthcare pty ltd - glucose, quantity: 45 g (equivalent: glucose monohydrate, qty 50 g) - injection - excipient ingredients: water for injections - glucose (5%) intravenous infusions are mainly indicated: - whenever non-electrolyte fluid replacement is required. - as a vehicle for drug delivery, provided that the added components are compatible with glucose.

BAXTER 5% GLUCOSE INTRAVENOUS INFUSION glucose 500mL bag 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

baxter 5% glucose intravenous infusion glucose 500ml bag

baxter healthcare pty ltd - glucose, quantity: 22.5 g (equivalent: glucose monohydrate, qty 25 g) - injection - excipient ingredients: water for injections - glucose (5%) intravenous infusions are mainly indicated: - whenever non-electrolyte fluid replacement is required. - as a vehicle for drug delivery, provided that the added components are compatible with glucose.

BAXTER 5% GLUCOSE INTRAVENOUS INFUSION glucose 250mL bag 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

baxter 5% glucose intravenous infusion glucose 250ml bag

baxter healthcare pty ltd - glucose, quantity: 11.25 g (equivalent: glucose monohydrate, qty 12.5 g) - injection - excipient ingredients: water for injections - glucose (5%) intravenous infusions are mainly indicated: - whenever non-electrolyte fluid replacement is required. - as a vehicle for drug delivery, provided that the added components are compatible with glucose.

BAXTER 0.15% POTASSIUM CHLORIDE AND 0.225% SODIUM CHLORIDE AND 3.75% GLUCOSE 500mL injection BP 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

baxter 0.15% potassium chloride and 0.225% sodium chloride and 3.75% glucose 500ml injection bp

baxter healthcare pty ltd - glucose, quantity: 37.5 g/l; sodium chloride, quantity: 2.25 g/l; potassium chloride, quantity: 1.5 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the potassium chloride ( 0.15%) and sodium chloride (0.225 %) and glucose (3.75 %) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.15% Potassium Chloride and 0.18% SODIUM CHLORIDE and 4% GLUCOSE 1000mL injection BPAHB1704 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

baxter 0.15% potassium chloride and 0.18% sodium chloride and 4% glucose 1000ml injection bpahb1704

baxter healthcare pty ltd - potassium chloride, quantity: 1.5 g/l; sodium chloride, quantity: 1.8 g/l; glucose, quantity: 40 g/l - injection, solution - excipient ingredients: water for injections - the potassium chloride ( 0.15%) and sodium chloride (0.18 %) and glucose (4 %) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.244% POTASSIUM CHLORIDE and 0.18% SODIUM CHLORIDE and 4% GLUCOSE 1000mL injection AHB1224 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

baxter 0.244% potassium chloride and 0.18% sodium chloride and 4% glucose 1000ml injection ahb1224

baxter healthcare pty ltd - glucose, quantity: 40 g/l; potassium chloride, quantity: 2.24 g/l; sodium chloride, quantity: 1.8 g/l - injection, solution - excipient ingredients: water for injections - the potassium chloride (0.224%), sodium chloride (0.18%), and glucose (4%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BUPIVACAINE-BAXTER bupivacaine hydrochloride (as monohydrate) 100 mg/20 mL solution for injection vial 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bupivacaine-baxter bupivacaine hydrochloride (as monohydrate) 100 mg/20 ml solution for injection vial

baxter healthcare pty ltd - bupivacaine hydrochloride, quantity: 5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 5.28 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections; sodium hydroxide - indications ,bupivacaine-claris is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: ,surgical anaesthesia ,epidural block for surgery ,field block (minor and major nerve blocks and infiltration). ,analgesia ,continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. ,field block (minor nerve block and infiltration).

LIDOCAINE-BAXTER lidocaine (lignocaine) hydrochloride (as monohydrate) 50 mg/5 mL solution for injection ampoule 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

lidocaine-baxter lidocaine (lignocaine) hydrochloride (as monohydrate) 50 mg/5 ml solution for injection ampoule

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 53.3 mg (equivalent: lidocaine hydrochloride, qty 50 mg) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.